Innovent's Sintilimab/Chemo Regime Shows Overall Survival Benefit In Gastric Cancer
Bristol Myers' Opdivo Scores European Approval As Adjuvant Treatment For Gastric Cancer
Hutchmed Stock Gains On Kick Starting Mid-Stage Gastric Cancer Trial With AstraZeneca's Orpathys
Merck To Withdraw Keytruda Accelerated Approval In Third-Line Gastric Cancer Setting